As many of you may have heard, last Thursday, June 6, 2019, was an historical day for our community. Emgality became the first ever FDA approved drug developed to prevent cluster headache. We couldn’t be more excited! In addition to having a new and much needed treatment for our disease, this news will offer some more awareness, which is always great. Clusterbusters hopes this will, in part, help to usher in a new era of awareness and advocacy for those living with cluster headache.
With this news has come many questions. Please follow this link or see below for more information on Emgality. As always, we are here to help and as we receive new information for Eli Lilly and Company we will pass this on to you.
- Eileen Brewer and the Clusterbusters Team